Friends of Leronlimab
A New Therapeutic Drug for Covid #Leronlimab
  Recent News From CytoDyn
View CytoDyn to Hold Webcast and Live Q/A on October 26
View CytoDyn Announces Delaware Court Has Denied Activist Group’s Motion to Prevent Annual Meeting from Taking Place
View CytoDyn Alerts Shareholders to Vote on Company’s Proxy Card Ahead of October 28th Annual Meeting
View Delaware Court Agrees with CytoDyn that Activist Group’s Nominations are Invalid
View CytoDyn to Present at Emerging Growth Conference on October 13 Followed by Live Q/A
View CytoDyn Announces Study to Evaluate Potential Synergistic Effects of Leronlimab with Immune Checkpoint Blockade (ICB)
View CytoDyn Names Chris Recknor, M.D. Senior Executive VP of Clinical Operations to Initiate Two New Clinical Trials for Stroke and Alzheimer’s, While Nitya Ray, Ph.D. is Named CytoDyn’s New COO to Lead CMC and Regulatory Operations Specifically the BLA for HIV
View CytoDyn Announces Legal Actions Against its Former CRO, Amarex Clinical Research
View CytoDyn Comments on Rosenbaum/Patterson Activist Group “Plan”
View CytoDyn to Present at Emerging Growth Conference on September 29 Followed by Live Q/A
This is a private website & not associated with CYDY, Leronlimab, Vyrologix, CytoDyn or All names, images & website links are the property of their respective owners.
Privacy Term of Service
© 2021